Mark L. Tykocinski

5.4k citations

90 papers · 4.4k indexed · 1 hit paper · h-index 38

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Reproductive System and Pregnancy
- Complement system in diseases
Cancer Research top 5%

Papers in

Immunology 51
- T-cell and B-cell Immunology 24
- Immune Cell Function and Interaction 21
- Immunotherapy and Immune Responses 18
Obstetrics and Gynecology 5

Co-authors: M. Edward Medof Yukiko Tone Masahide Tone Keiji Furuuchi Yoshitsugu Kojima Mark I. Greene Jacob Rachmilewitz Edward E. Max
Journals: The Journal of Immunology (12 papers)Proceedings of the National Academy of Sciences (7 papers)Cellular Immunology (4 papers)FEBS Letters (4 papers)International Immunology (3 papers)
Partner nations: United States Israel United Kingdom

In The Last Decade

Mark L. Tykocinski

90 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer 2007 · 634 citations

Peers

Countries citing papers authored by Mark L. Tykocinski

Since Specialization

Citations

This map shows the geographic impact of Mark L. Tykocinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Tykocinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Tykocinski more than expected).

Fields of papers citing papers by Mark L. Tykocinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Tykocinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Tykocinski. The network helps show where Mark L. Tykocinski may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark L. Tykocinski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark L. Tykocinski Line = papers co-authored together Mark L. Tykocinski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Toxicology and Pharmacokinetic Studies in Mice and Nonhuman Primates of the Nontoxic, Efficient, Targeted Hexameric FasL: CTLA4-FasL Molecular Cancer Therapeutics ·Efi Makdasi, R SH.AL-Khafajy, Alexandra Aronin, Tatyana B. Prigozhina, Justin D. Estep, Yosi Gozlan, Jennie Mårtensson, Jitka Yehudith Sagiv, Т. С. Медведкин, Noam Shani, Mark L. Tykocinski, Anna Leuteritz	2019	3
2	Dealing With Deans and Academic Medical Center Leadership Academic Pathology ·Fred Sanfilippo, Deborah E. Powell, Robert Folberg, Mark L. Tykocinski	2018	8
3	HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells Molecular Cancer Research ·Tibor Cserháti, S. Madhumithaa, Mahsa Zarei, Trevor Baker, Saswati N. Chand, N. S. Zav'yalova, Jordan M. Winter, Janet A. Sawicki, Jonathan N. Sachs, Nicole Meisner‐Kober, Charles J. Yeo, Rajanikanth Vadigepalli, Mark L. Tykocinski, Jonathan R. Brody	2016	48
4	Can Empathy, Other Personality Attributes, and Level of Positive Social Influence in Medical School Identify Potential Leaders in Medicine? Academic Medicine ·Mohammadreza Hojat, Barret Michalec, J. Jon Veloski, Mark L. Tykocinski	2015	34
5	Fn14•Trail Effectively Inhibits Hepatocellular Carcinoma Growth PLoS ONE ·Alexandra Aronin, R SH.AL-Khafajy, Tatyana B. Prigozhina, Justin D. Estep, Jacob Rachmilewitz, Noam Shani, Mark L. Tykocinski, Anna Leuteritz	2013	15
6	CD40·FasL and CTLA-4·FasL Fusion Proteins Induce Apoptosis in Malignant Cell Lines by Dual Signaling American Journal Of Pathology ·Ariel Orbach, Jacob Rachmilewitz, Noam Shani, María Cristina Castellanos Sierra Cristina Castellanos Sierra, T. Karimzada, 陈关兴, Mark L. Tykocinski, 眞紀夫石澤	2010	11
7	Welcome and Opening Remarks The Medicine Forum ·Karina Pasquale, Mark L. Tykocinski	2007	1
8	CTLA-4 · FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals The Journal of Immunology ·Ariel Orbach, Jacob Rachmilewitz, Yun-Ling Fang, 陈关兴, Mark L. Tykocinski, Paúl Oswaldo Sarango Lalangui	2007	24
9	Pathology as the enabler of human research Laboratory Investigation ·James M. Crawford, Mark L. Tykocinski	2005	16
10	Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production Cellular Immunology ·Sachi Katira, Lorri Santamaría, S. Madhumithaa, Mark L. Tykocinski, Peter H. Koo	2004	59
11	CTLA-4 · FasL Induces Alloantigen-Specific Hyporesponsiveness The Journal of Immunology ·Anna Leuteritz, 陈关兴, William M. Schmidt, Jacob Rachmilewitz, Mark L. Tykocinski	2003	24
12	Negative Regulation of T Cell Activation by Placental Protein 14 Is Mediated by the Tyrosine Phosphatase Receptor CD45 Journal of Biological Chemistry ·Jacob Rachmilewitz, Zipora Borovsky, Gregory J. Riely, R Eric Miller, Mark L. Tykocinski	2003	47
13	Hierarchical Costimulator Thresholds for Distinct Immune Responses: Application of a Novel Two-Step Fc Fusion Protein Transfer Method The Journal of Immunology ·Aoshuang Chen, Guoxing Zheng, Mark L. Tykocinski	2000	38
14	Glycosyl-Phosphatidylinositol Reanchoring Unmasks Distinct Antigen-Presenting Pathways for CD1b and CD1c The Journal of Immunology ·David Geho, John D. Fayen, Helen Gibson, D. Branch Moody, Steven A. Porcelli, Mark L. Tykocinski	2000	10
15	Glycerolphosphoinositide anchors for membrane-tethering proteins Methods in enzymology on CD-ROM/Methods in enzymology ·John D. Fayen, Mark L. Tykocinski, M. Edward Medof	2000	2
16	Protein Transfer of Glycosyl-Phosphatidylinositol (GPI)-Modified Murine B7–1 and B7–2 Costimulators Journal of Immunotherapy ·V Harinisri, John D. Fayen, M. Edward Medof, Mark L. Tykocinski	1999	24
17	A receptor for the lipocalin placental protein 14 on human monocytes FEBS Letters ·R Eric Miller, John D. Fayen, Subrata Chakraborty, S. Madhumithaa, Mark L. Tykocinski	1998	33
18	C‐FMS dependent HL‐60 cell differentiation and regulation of RB gene expression Journal of Cellular Physiology ·Andrew Yen, M. Elizabeth Forbes, Susi Varvayanis, Mark L. Tykocinski, Richard K. Groger, 韦小坚	1993	22
19	Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors Gene ·Richard K. Groger, Dwight M. Morrow, Mark L. Tykocinski	1989	75
20	Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. Journal of Clinical Investigation ·Nai‐Kong V. Cheung, E I Walter, Yongming Du, William D. Ratnoff, Mark L. Tykocinski, M. Edward Medof	1988	118

About Mark L. Tykocinski

Mark L. Tykocinski is a scholar working on Immunology, Obstetrics and Gynecology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 90 papers that have together received 4.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (24 papers), Immune Cell Function and Interaction (21 papers), Immunotherapy and Immune Responses (18 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Virus-based gene therapy research (8 papers), Cell death mechanisms and regulation (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Immunology (2.1k citations), Cancer Research (432 citations), Molecular Biology (1.8k citations), Immunology and Allergy (154 citations) and Oncology (597 citations). Mark L. Tykocinski has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include M. Edward Medof, Yukiko Tone, Masahide Tone, Keiji Furuuchi, Yoshitsugu Kojima, Mark I. Greene, Jacob Rachmilewitz, Edward E. Max, Robert R. Getty and Dwight M. Morrow. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, Cellular Immunology, FEBS Letters and International Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact